Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cytosorbents (CTSO) Change in Inventory (2016 - 2025)

Cytosorbents (CTSO) has disclosed Change in Inventory for 14 consecutive years, with $322000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Change in Inventory rose 127.22% year-over-year to $322000.0, compared with a TTM value of $899534.0 through Sep 2025, up 563.62%, and an annual FY2024 reading of -$500466.0, down 173.07% over the prior year.
  • Change in Inventory was $322000.0 for Q3 2025 at Cytosorbents, down from $726198.0 in the prior quarter.
  • Across five years, Change in Inventory topped out at $996441.0 in Q3 2021 and bottomed at -$1.7 million in Q1 2023.
  • Average Change in Inventory over 5 years is $103602.9, with a median of $297263.0 recorded in 2023.
  • The sharpest move saw Change in Inventory surged 535820.97% in 2021, then crashed 311.17% in 2023.
  • Year by year, Change in Inventory stood at $251496.0 in 2021, then tumbled by 293.21% to -$485918.0 in 2022, then skyrocketed by 159.38% to $288549.0 in 2023, then tumbled by 220.42% to -$347466.0 in 2024, then skyrocketed by 192.67% to $322000.0 in 2025.
  • Business Quant data shows Change in Inventory for CTSO at $322000.0 in Q3 2025, $726198.0 in Q2 2025, and $198802.0 in Q1 2025.